skip to main content

Haem02 Blood Substitute Project Shortlisted for National Award

Haem02 Blood Substitute Project Shortlisted for National Award

29 October 2014

An innovative Essex-based project to develop a one-size-fits-all, third generation artificial blood substitute has been shortlisted for a national award.

Led by Professor Chris Cooper, from the School of Biological Sciences, the Haem02 team are developing an artificial blood substitute that is a safe, long-lasting, virus-free alternative to current blood transfusions.

The project has been shortlisted in the “Best New Medtech Development Programme” category of the OBN Annual Awards, which honours the best of UK bioscience, diagnostics and medtech companies.

Haemoglobin is the key protein in red blood cells that carries oxygen around our bodies. The Haem02 team aim to create an artificial haemoglobin-based oxygen carrier that could be used as a substitute for blood lost in surgery or trauma. Their engineered haemoglobin product has already been granted patents in the US and Australia and has a patent pending in the EU.